CPF, Pulmonary Fibrosis Experts Guests on Sirius and XM Satellite Radio Show June 16th

CPF, Pulmonary Fibrosis Experts Guests on Sirius and XM Satellite Radio Show June 16th

"Doctor Radio" Host Interviews CPF Co-Founder, PF Advocate, and Top PF Researcher and Clinician

NEW YORK, June 15 /PRNewswire-USNewswire/ -- The Coalition for Pulmonary Fibrosis (CPF) today announced its co-founder and other Pulmonary Fibrosis (PF) experts will be guests on the Sirius and XM Satellite Radio Show "Doctor Radio" on Tuesday, June 16th from 6-7 a.m. EDT. For non-Sirius and XM radio subscribers, the show can be heard via a free pass available on the Internet.

Sirius and XM Satellite Radio Interview with CPF, PF Experts

Show: Doctor Radio

Host: Frank Adams, MD

Subject: Pulmonary Fibrosis

Guests: Coalition for Pulmonary Fibrosis Chief Operating Officer and Co-Founder Mark Shreve; Family member of PF patient, legislative advocate and CPF fundraiser Terence Hales; and pulmonologist and world renowned PF researcher and clinician, Maria Padilla, MD, of Mount Sinai Medical Center in New York City.

Date: Tuesday, June 16th, 2009

Time: 6-7 a.m., EDT

Listen online: To listen to the interview online, sign up with an email address for a free pass at http://www.sirius.com/freetrial/register.

Listeners can hear the show live on Tuesday, June 16th or can listen to the repeat which airs from 4-6 p.m. EDT on Tuesday, June 16th. Sirius and XM Satellite Radio subscribers can also listen in on satellite radio.

About Pulmonary Fibrosis (PF)

Pulmonary Fibrosis (PF) is a lung disorder characterized by a progressive scarring - known as fibrosis -- and deterioration of the lungs, which slowly robs its victims of their ability to breathe. Approximately 128,000 Americans suffer from PF, and there is currently no known cause or cure. An estimated 48,000 new cases are diagnosed each year. PF is difficult to diagnose and an estimated two-thirds of patients die within five years of diagnosis. Sometimes PF can be linked to a particular cause, such as certain environmental exposures, chemotherapy or radiation therapy, residual infection, or autoimmune diseases such as scleroderma or rheumatoid arthritis. However, in many instances, no known cause can be established. When this is the case, it is called idiopathic pulmonary fibrosis (IPF).

About the CPF

The CPF is a 501(c)(3) nonprofit organization, founded in 2001 to accelerate research efforts leading to a cure for pulmonary fibrosis (PF), while educating, supporting, and advocating for the community of patients, families, and medical professionals fighting this disease. The CPF funds promising research into new approaches to treat and cure PF; provides patients and families with comprehensive education materials, resources, and hope; serves as a voice for national advocacy of PF issues; and works to improve awareness of PF in the medical community as well as the general public. The CPF's nonprofit partners include many of the most respected medical centers and healthcare organizations in the U.S. With more than 19,000 members nationwide, the CPF is the largest nonprofit organization in the U.S. dedicated to advocating for those with PF. For more information please visit www.coalitionforpf.org or call (888) 222-8541.

Source: Coalition for Pulmonary Fibrosis

CONTACT: Teresa Barnes of the Coalition for Pulmonary Fibrosis,
+1-303-521-4080, tbarnes@coalitionforpf.org

Web Site: http://www.coalitionforpf.org/

-------
Profile: intent